No headlines found.
Globe Newswire (Thu, 10-Jul 4:05 PM ET)
Alignment Healthcare Wins Key Legal Victory: Arizona Medicare Advantage Plans Elevated to 4 Stars
Globe Newswire (Tue, 8-Jul 8:00 AM ET)
Alignment Healthcare Founder and CEO John Kao Named to AHIP Board
Globe Newswire (Tue, 10-Jun 8:00 AM ET)
Alignment Healthcare Named to 2025 Fortune 1000 List Following Strong Revenue Growth
Globe Newswire (Tue, 3-Jun 8:00 AM ET)
Alignment Healthcare to Present at William Blair 45th Annual Growth Stock Conference
Globe Newswire (Wed, 21-May 8:00 AM ET)
Globe Newswire (Mon, 19-May 8:00 AM ET)
Globe Newswire (Thu, 1-May 4:01 PM ET)
Alignment Healthcare to Present at the BofA Securities Healthcare Conference
Globe Newswire (Mon, 28-Apr 8:00 AM ET)
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Alignment Healthcare trades on the NASDAQ stock market under the symbol ALHC.
As of July 17, 2025, ALHC stock price declined to $13.20 with 735,754 million shares trading.
ALHC has a beta of 0.62, meaning it tends to be less sensitive to market movements. ALHC has a correlation of 0.04 to the broad based SPY ETF.
ALHC has a market cap of $2.53 billion. This is considered a Mid Cap stock.
Last quarter Alignment Healthcare reported $927 million in Revenue and -$.05 earnings per share. This beat revenue expectation by $39 million and exceeded earnings estimates by $.02.
In the last 3 years, ALHC traded as high as $21.06 and as low as $4.46.
The top ETF exchange traded funds that ALHC belongs to (by Net Assets): VTI, VB, IWM, VBK, VXF.
ALHC has outperformed the market in the last year with a return of +33.7%, while the SPY ETF gained +12.3%. However, in the most recent history, ALHC shares have underperformed the stock market with its stock returning -32.2% in the last 3 month period and -3.0% for the last 2 week period, while SPY has returned +19.7% and +1.1%, respectively.
ALHC support price is $13.07 and resistance is $13.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALHC shares will trade within this expected range on the day.